Rising CKD in Germany: New Treatments Offer Hope, but Long-Term Outlook Remains Complex
Chronic kidney disease (CKD) in Germany is rising, primarily driven by arterial hypertension and type 2 diabetes. New treatments like SGLT2 inhibitors and Finerenone are now available, but the condition can lead to severe complications and has a long-term outlook that depends on various factors.
CKD occurs when kidneys are damaged and can no longer effectively filter waste from the body. Risk factors include smoking, obesity, diabetes, heart disease, high cholesterol, family history of kidney disease, and being over 65. Causes range from diabetes and high blood pressure to kidney infections and autoimmune disorders. Diagnosis involves physical exams, blood and urine tests, imaging, and biopsy. Symptoms can include high blood pressure, swelling, urinary tract infections, and fatigue, among others. Treatment includes dietary changes, medication, and lifestyle adjustments. End-stage treatment involves dialysis or a kidney transplant.
With improved treatment options like SGLT2 inhibitors and Finerenone, managing CKD in Germany has become more effective. However, the long-term outlook depends on individual lifestyle changes, medication, dialysis, or transplant, and potential complications such as heart failure, nerve damage, and infertility.
Read also:
- Americans Lose Insurance Under New Tax Legislation, Affecting 10 Million Citizens
- Pro-Life Group Condemns FDA's Approval of Generic Abortion Drug
- Trump Signs Law Defunding Planned Parenthood, Threatening Healthcare Access for Millions
- Historian Ute Frevert Explores Germans' Emotional Bond With Constitutions
